Form C-AR — iMetabolic Biopharma Corporation
0001665160-24-001088 · filed Jul 19, 2024
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 1957114
- Entity
- Corporation
- Jurisdiction
- NV
- Address
- 275 N Gateway Dr, Suite 104
Phoenix, AZ 85034 - Phone
- —
Most recent fiscal year financials
- Total assets
- $100,587
- Cash
- —
- Short-term debt
- $8,949
- Long-term debt
- $455,843
- Revenues
- $76,803
- COGS
- —
- Taxes paid
- —
- Net income
- $-200,806
View the original filing on SEC EDGAR ↗